What is NDC 70518-4570?

70518-4570 is the product NDC for buprenorphine hydrochloride, Buprenorphine hydrochloride 2 mg/1 tablet, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.

REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for buprenorphine hydrochloride?

12 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

buprenorphine hydrochloride NDC 70518-4570

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-4570Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-4570Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-4570-0	7051845700070518457000	30 POUCH in 1 BOX (70518-4570-0) / 1 TABLET in 1 POUCH (70518-4570-1)Marketed from Feb 10, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): buprenorphine hydrochloride
Generic name (nonproprietary): buprenorphine hydrochloride
Active ingredients: Buprenorphine hydrochloride — 2 mg/1
Dosage form: Tablet
Route: Sublingual
Labeler: REMEDYREPACK INC.NDC labeler code 70518
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090279
Marketing start: Feb 10, 2026
Listing expires: Dec 31, 2027
DEA schedule: CIII
Other FDA classes: Partial Opioid Agonists (Mechanism)
Identifiers: Product ID 70518-4570_5badf22c-8461-1e0e-e063-6294a90aa37cSPL ID 5badf22c-8461-1e0e-e063-6294a90aa37c
Pharmacologic class: Partial Opioid Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Sublingual products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518457000 followed by a unit qualifier and the quantity

Package 70518-4570-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 70518-4570

What is NDC 70518-4570?: 70518-4570 is the product NDC for buprenorphine hydrochloride, Buprenorphine hydrochloride 2 mg/1 tablet, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: buprenorphine hydrochloride.
What is the active ingredient?: Buprenorphine hydrochloride.
Who is the labeler?: REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for buprenorphine hydrochloride?: 12 other product NDCs are listed under this name. See all buprenorphine hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other buprenorphine hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
buprenorphine hydrochloride	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	REMEDYREPACK INC.	70518-4571	70518-4571-0070518-4571-02
buprenorphine hydrochloride	Buprenorphine hydrochloride 12 mg/1	TabletSublingual	Advagen Pharma Ltd	72888-510	72888-0510-0172888-0510-02
Buprenorphine Hydrochloride	Buprenorphine hydrochloride .324 mg/mL	InjectionIntramuscular, Intravenous	Somerset Therapeutics, LLC	70069-027	70069-0027-05
buprenorphine hydrochloride	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	PAI Holdings, LLC dba PAI Pharma	0121-1019	00121-1019-30
buprenorphine hydrochloride	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	PAI Holdings, LLC dba PAI Pharma	0121-2038	00121-2038-30
buprenorphine hydrochloride	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	A-S Medication Solutions	50090-7559	50090-7559-00
Buprenorphine Hydrochloride	Buprenorphine hydrochloride .324 mg/mL	InjectionIntramuscular, Intravenous	Par Health USA, LLC	42023-179	42023-0179-05
buprenorphine hydrochloride	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	Advagen Pharma Ltd	72888-182	72888-0182-3072888-0182-90
buprenorphine hydrochloride	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	Advagen Pharma Ltd	72888-183	72888-0183-3072888-0183-90
buprenorphine hydrochloride	Buprenorphine hydrochloride 4 mg/1	TabletSublingual	Advagen Pharma Ltd	72888-509	72888-0509-0172888-0509-02

All 13 buprenorphine hydrochloride NDCs

Other NDCs under ANDA 090279

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090279
Product	Strength	Form · route	Labeler	Product NDC
buprenorphine hydrochloride	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	Advagen Pharma Ltd	72888-182
buprenorphine hydrochloride	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	Advagen Pharma Ltd	72888-183
buprenorphine hydrochloride	Buprenorphine hydrochloride 4 mg/1	TabletSublingual	Advagen Pharma Ltd	72888-509
buprenorphine hydrochloride	Buprenorphine hydrochloride 12 mg/1	TabletSublingual	Advagen Pharma Ltd	72888-510